Genus Pharmaceuticals

Park View House, 65 London Road, Newbury, Berkshire, RG14 1JN
Telephone: +44 (0)1635 568 400
Fax: +44 (0)1635 568 401
Medical Information Direct Line: +44 (0)870 851 0207
Medical Information e-mail: genus@medinformation.co.uk
Customer Care direct line: +44 (0)1635 568 445
Medical Information Fax: +44 (0)1793 710 387

Patient Information Leaflet last updated on the eMC: 09/03/2010
PIL APO-go Pen 10mg/ml Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/03/2010 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 29/01/2010 and displayed until 09/03/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Addition of Marketing Authorisation Holder
Updated on 18/09/2009 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 02/09/2009 and displayed until 18/09/2009
Reasons for adding or updating:
  • Change of manufacturer
Updated on 04/11/2008 and displayed until 02/09/2009
Reasons for adding or updating:
  • Change of licence holder
Updated on 30/07/2007 and displayed until 04/11/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/07/2005 and displayed until 30/07/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/06/2003 and displayed until 11/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   apomorphine hydrochloride